title: Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.
abstract: There is no universal agreement on the definition of anaphylaxis or the criteria for diagnosis. In July 2005, the National Institute of Allergy and Infectious Disease and Food Allergy and Anaphylaxis Network convened a second meeting on anaphylaxis, which included representatives from 16 different organizations or government bodies, including representatives from North America, Europe, and Australia, to continue working toward a universally accepted definition of anaphylaxis, establish clinical criteria that would accurately identify cases of anaphylaxis with high precision, further review the evidence on the most appropriate management of anaphylaxis, and outline the research needs in this area.
authors.affiliation: Division of Pediatric Allergy and Immunology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA. hugh.sampson@mssm.edu
authors.forename: Hugh A
authors.initials: HA
authors.lastname: Sampson
authors.forename: Anne
authors.initials: A
authors.lastname: Muñoz-Furlong
authors.forename: Ronna L
authors.initials: RL
authors.lastname: Campbell
authors.forename: N Franklin
authors.initials: NF
authors.lastname: Adkinson
authors.forename: S Allan
authors.initials: SA
authors.lastname: Bock
authors.forename: Amy
authors.initials: A
authors.lastname: Branum
authors.forename: Simon G A
authors.initials: SG
authors.lastname: Brown
authors.forename: Carlos A
authors.initials: CA
authors.lastname: Camargo
authors.forename: Rita
authors.initials: R
authors.lastname: Cydulka
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Galli
authors.forename: Jane
authors.initials: J
authors.lastname: Gidudu
authors.forename: Rebecca S
authors.initials: RS
authors.lastname: Gruchalla
authors.forename: Allen D
authors.initials: AD
authors.lastname: Harlor
authors.forename: David L
authors.initials: DL
authors.lastname: Hepner
authors.forename: Lawrence M
authors.initials: LM
authors.lastname: Lewis
authors.forename: Phillip L
authors.initials: PL
authors.lastname: Lieberman
authors.forename: Dean D
authors.initials: DD
authors.lastname: Metcalfe
authors.forename: Robert
authors.initials: R
authors.lastname: O'Connor
authors.forename: Antonella
authors.initials: A
authors.lastname: Muraro
authors.forename: Amanda
authors.initials: A
authors.lastname: Rudman
authors.forename: Cara
authors.initials: C
authors.lastname: Schmitt
authors.forename: Debra
authors.initials: D
authors.lastname: Scherrer
authors.forename: F Estelle R
authors.initials: FE
authors.lastname: Simons
authors.forename: Stephen
authors.initials: S
authors.lastname: Thomas
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Wood
authors.forename: Wyatt W
authors.initials: WW
authors.lastname: Decker
mesh_terms: D000707:Anaphylaxis / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004837:Epinephrine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000209:etiology; D007073:Immunoglobulin E / Q000097:blood
chemical_list: D001993:Bronchodilator Agents; D007073:Immunoglobulin E; D004837:Epinephrine